Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality, often diagnosed at advanced stages due to a lack of sensitive early detection tools.
This article provides a comprehensive analysis of the two dominant paradigms in molecular recognition—conformational selection and induced fit—and their critical implications for structure-based drug discovery.
This comprehensive review explores the molecular basis of protein-small molecule binding thermodynamics, addressing the critical needs of researchers and drug development professionals.
Hepatocellular carcinoma (HCC) is a global health threat with a poor prognosis, largely due to late diagnosis.
This comprehensive review synthesizes current evidence on the long non-coding RNA LINC00152 as a potent independent prognostic biomarker in hepatocellular carcinoma (HCC).
Liquid biopsy has emerged as a transformative, non-invasive approach for the management of hepatocellular carcinoma (HCC).
Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality worldwide, with a 5-year survival rate below 20% for advanced-stage patients.
This article synthesizes current advancements in validating long non-coding RNA (lncRNA) biomarkers for hepatocellular carcinoma (HCC) prognosis using multivariate Cox regression models.
Hepatocellular carcinoma (HCC) is a global health challenge with high mortality, largely due to late diagnosis.
Hepatocellular carcinoma (HCC) presents a significant global health burden, with poor prognosis often due to late diagnosis.